HomeTagsCYAD-101-002

CYAD-101-002

Biotechnology

Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial

Business Wire - August 1, 2022

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...

Healthcare

Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial

Business Wire - February 28, 2022

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...